MedTrace Logo

Myofascial Release With and Without Autogenic Inhibition Muscle Energy Technique in Non-specific Chronic Neck Pain

NCT07331571 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-01-12

No results posted yet for this study

Summary

The study was conducted to determine the effects of myofascial release therapy with and without autogenic inhibition muscle energy technique in patients with non-specific chronic neck pain.

Conditions

  • Non Specific Chronic Neck Pain

Interventions

OTHER

Autogenic Inhibition Muscle Energy Technique

AI MET was applied for upper trapezius 5 times for each side, similarly for levator scapulae it was applied 5 times for each side. AI MET was applied for posterior, middle and anterior fibres of scalene muscle. For sternocleidomastoid muscle it was applied for at least twice for each side. 8 sessions were conducted for 6 weeks, with 3 sessions scheduled every week.

OTHER

Myofasical Release Therapy

MFR for upper trapezius and levator scapulae was carried out 5 times for each side. A total of 18 sessions were conducted for 6 weeks, with 3 sessions scheduled every week.

OTHER

Standardized Physiotherapy Treatment

Electric hot pack for 10 minutes for 10 minutes, TENS with frequency of 120Hz at low intensity having pulse duration of 50-200μs for 10 minutes \& Grade I and II Maitland posteroanterior central glide with 3 sets of 30 oscillations, for alleviation of pain at the target vertebral segment.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Shakil ur Rehman, Ph.D · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-13
Primary Completion
2025-05-31
Completion
2025-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07331571 on ClinicalTrials.gov